Gyre Therapeutics, Inc. (GYRE)
NASDAQ: GYRE · Real-Time Price · USD
4.430
-0.010 (-0.23%)
At close: Nov 4, 2026, 4:00 PM EST
4.442
+0.012 (0.26%)
After-hours: Nov 4, 2026, 5:57 PM EST
Gyre Therapeutics Market Cap
Gyre Therapeutics has a market cap or net worth of $469.73 million as of November 4, 2026. It is the 14,651st most valuable company in the world and the 2,767th biggest in the United States. Its market cap has decreased by 29.73% in one year.
Market Cap
469.73M
Enterprise Value
398.35M
1-Year Change
-29.73%
Global Rank
Country Rank
#2,767 United States
Category
ChartMarket Cap Chart
Since October 31, 2023, Gyre Therapeutics's market cap has decreased from $515.41M to $469.73M, a decrease of -8.86%. That is a compound annual growth rate of -3.03%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 4, 2026 | 469.73M | -26.80% |
| Dec 31, 2025 | 641.69M | -38.21% |
| Dec 31, 2024 | 1.04B | -47.22% |
| Dec 29, 2023 | 1.97B | 281.72% |
| Oct 31, 2023 | 515.41M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Capricor Therapeutics | 479.07M |
| CytomX Therapeutics | 475.02M |
| MiMedx Group | 474.26M |
| Oculis Holding AG | 471.02M |
| Monopar Therapeutics | 469.11M |
| Ovid Therapeutics | 468.71M |
| Arvinas | 463.59M |
| Phathom Pharmaceuticals | 455.93M |